ici 118551 and gemcitabine

ici 118551 has been researched along with gemcitabine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guo, K; Liu, H; Ma, Q; Shan, T; Wang, F; Wu, E; Zhang, D	1

Other Studies

1 other study(ies) available for ici 118551 and gemcitabine

Article	Year
β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction. European journal of pharmacology, 2011, Aug-31, Volume: 665, Issue:1-3 Topics: Adrenergic beta-2 Receptor Antagonists; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Synergism; Gemcitabine; Humans; NF-kappa B; Pancreatic Neoplasms; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Receptors, Adrenergic, beta-2	2011

Article

Year

β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction.

European journal of pharmacology, 2011, Aug-31, Volume: 665, Issue:1-3

Topics: Adrenergic beta-2 Receptor Antagonists; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Drug Synergism; Gemcitabine; Humans; NF-kappa B; Pancreatic Neoplasms; Propanolamines; Proto-Oncogene Proteins c-bcl-2; Receptors, Adrenergic, beta-2

2011